S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SILO Silo Pharma Inc

0.993649

0.00566 (0.57%)

Jan 06 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Silo Pharma (NASDAQ:SILO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Silo Pharma Charts.

Silo Pharma (NASDAQ:SILO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Silo Pharma Charts.

Silo Pharma Inc News

Form 8-K - Current report
Thursday 2 January 2025 (4 days ago) • Edgar (US Regulatory)

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain
Thursday 2 January 2025 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
Wednesday 18 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
Friday 29 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
Monday 18 November 2024 (2 months ago) • GlobeNewswire Inc.

Form DEFR14A - Revised definitive proxy soliciting materials
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

More Silo Pharma Inc News Articles

TPT Global Tech (CE)

Lehman Brothers Financial (CE)

Valiant Eagle (PK)

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

Moon Equity (PK)

Federal Home Loan Mortgage (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions